2025 News Feed
Pennington Biomedical Research Center’s June Small Shifts Focus: Adding More Fruits and Vegetables to Diets
Pennington Biomedical Research Center announces the June Small Shifts campaign focus is adding more fruits and vegetables to diets. This month’s shift encourages individuals and families to make simple, sustainable changes that can lead to lasting improvements in overall health and wellness.
Learn More
The Art of the Snackle Box
Let’s be honest—nothing brightens up a long drive quite like the promise of a tasty treat: a delicious, indulgent spark of excitement to break up the monotony of long hours spent on the road. But in the chaos of pre-departure vacation planning, snack-packing often gets left off the to-do list, only to be replaced by a gas station stop or drive-thru run on the way. Oftentimes, this means bags of chips or candy, greasy fast food and sugary drinks—which, while convenient, might make the journey less enjoyable, and healthful, in the long run.
Learn More
Pennington Biomedical Leads the Way in Redefining Obesity Diagnosis Beyond BMI
Pennington Biomedical Research Center, a leader in obesity research and treatment, recently played a pivotal role in reshaping how clinical obesity is understood. Three of its researchers served on the prestigious Lancet Commission on Clinical Obesity, a global initiative comprising 56 experts worldwide.
Learn More
Pennington Biomedical Researchers to Present at NUTRITION 2025 Conference in Orlando
Researchers from Pennington Biomedical Research Center are scheduled to present their research findings at NUTRITION 2025, the annual flagship meeting for the American Society of Nutrition, or ASN, taking place in Orlando, Florida, May 31 – June 3.
Learn More
Dr. Jacob Mey Discusses Using Your Unique Biology and Goals to Determine YOUR Best Meal Plan
What if your diet was as unique to you as your own biology, environment, socio-economic factors, individual preferences, and goals? Pennington Biomedical Assistant Professor Jacob Mey, PhD, RD posed this exact question to those gathered at the most recent Scientific Dinner hosted by Pennington Biomedical Research Foundation.
Learn More
Pennington Biomedical Welcomes Dr. Stefan Pasiakos as Director of the Center for Human Performance Optimization
Pennington Biomedical Research Center is pleased to announce that Stefan Pasiakos, PhD, has joined the faculty as Professor and Director of Human Performance Optimization. In this role, Dr. Pasiakos will lead groundbreaking research aimed at enhancing human performance and physiology across diverse environments – from the battlefield to deep space.
Learn More
Pennington Biomedical Highlights How Cellular Quality Control Contribute to Insulin Resistance Related to Type 2 Diabetes
Researchers at Pennington Biomedical Research Center have revealed critical insights into how impaired mitochondrial dynamics and quality control mechanisms in skeletal muscle influence insulin sensitivity in patients with Type 2 Diabetes, or T2D. The study, titled "Deubiquitinating Enzymes Regulate Skeletal Muscle Mitochondrial Quality Control and Insulin Sensitivity in Patients with Type 2 Diabetes," was recently published in the Journal of Cachexia, Sarcopenia and Muscle.
Learn More
Dr. Adithya Hari Joins Pennington Biomedical as Physician/Nuclear Oncologist, Adds to Center’s Strategic Expansion of Cancer Metabolism Program
Pennington Biomedical Research Center is pleased to announce the arrival of Dr. Adithya Hari, MD, as Assistant Professor and Physician/Nuclear Oncologist in the Division of Clinical Science, effective April 21. Dr. Hari’s recruitment represents a strategic expansion of Pennington Biomedical’s research capacity in cancer metabolism and nuclear medicine and was a collaborative effort involving Pennington Biomedical partners Mary Bird Perkins Cancer Center, Louisiana Cancer Research Center, and LSU Health New Orleans.
Learn More
Special Guests Visit Pennington Biomedical
This month, Pennington Biomedical welcomed renowned neurosurgeon and former U.S. Secretary of Housing and Urban Development Dr. Ben Carson to tour the Center and discover more about the incredible science and research conducted here. Touring with his wife, Candy Carson, Dr. Carson was shown around by scientists and staff who briefed them on the research findings and studies that have taken place over the past 35 years, as well as discussing with them the next steps in discovering the triggers of chronic disease.
Learn More
Long-Term Benefits of Lifestyle and Metformin Interventions in Reducing Type 2 Diabetes Over 21 Years in the U.S. Diabetes Prevention Program Study
The U.S. Diabetes Prevention Program, or DPP, reported on April 28 the 21-year follow-up of this randomized clinical trial showing that the original intensive lifestyle intervention reduced the development of diabetes by 24% and metformin reduced diabetes development by 17%. The DPP had previously showed that after the first 3 years of study, the intensive lifestyle, aimed at moderate weight loss and increased physical activity, and the medication metformin reduced the onset of type 2 diabetes by 58% and 31%, respectively, compared with a placebo medicine. All participants were adults at high risk of developing diabetes.
Learn More
